Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Jazz Pharmaceuticals plc | Financial_Report.xls |
| 10-Q - 10-Q - Jazz Pharmaceuticals plc | jazz2015q1doc.htm |
| EX-10.2 - OFFER LETTER - Jazz Pharmaceuticals plc | jazzq12015ex102.htm |
| EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plc | jazzq12015ex312.htm |
| EX-32.1 - CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - Jazz Pharmaceuticals plc | jazzq12015ex321.htm |
| EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plc | jazzq12015ex311.htm |
Exhibit 10.3
2015 Executive Officer Compensation Arrangements
Executive Officer | Base Salary Rate(1) | Target Bonus as % of Annual Base Salary Rate(2) |
Bruce C. Cozadd Chairman and Chief Executive Officer | $875,000 | 100 |
Russell J. Cox Executive Vice President and Chief Operating Officer | $550,000 | 55 |
Suzanne Sawochka Hooper Executive Vice President and General Counsel | $500,000 | 55 |
Matthew P. Young Executive Vice President and Chief Financial Officer | $475,000 | 55 |
Iain McGill Senior Vice President, Jazz Pharmaceuticals Europe and Rest of World | £240,000 | 45 |
Michael P. Miller Senior Vice President, U.S. Commercial | $430,000 | 45 |
Karen Smith, M.D., Ph.D. Global Head of Research & Development and Chief Medical Officer | $475,000 | 45 |
Paul Treacy Senior Vice President, Technical Operations | €250,800 | 45 |
Karen J. Wilson Senior Vice President, Finance and Principal Accounting Officer | $310,000 | 45 |
(1) | 2015 Base salary rates generally effective by March 1, 2015. Dr. Smith’s base salary rate is effective beginning on April 13, 2015, the commencement date of her employment. |
(2) | Target bonus percentage for each officer is based on his or her position and/or responsibility level as provided in Jazz Pharmaceuticals plc’s cash bonus plans. |